{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:27:53Z","timestamp":1781900873307,"version":"3.54.5"},"reference-count":72,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.drudis.2020.05.003","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T13:07:34Z","timestamp":1589980054000},"page":"1293-1297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic profile considerations for induction of allogeneic chimerism as a therapeutic approach for type 1 diabetes mellitus"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4463-3550","authenticated-orcid":false,"given":"Labe A.","family":"Black","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Zorina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2020.05.003_bib0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/bmj.1.3236.8","article-title":"Further clinical experience with insulin (pancreatic extracts) in the treatment of diabetes mellitus","volume":"1","author":"Banting","year":"1923","journal-title":"Br. Med. J."},{"key":"10.1016\/j.drudis.2020.05.003_bib0010","first-page":"565","article-title":"Observations with insulin on Department of Soldiers\u2019 civil re-establishment diabetics","volume":"13","author":"Gilchrist","year":"1923","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.drudis.2020.05.003_bib0015","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.biomaterials.2005.08.011","article-title":"Glucose-responsive UV polymerised dextran-concanavalin A acrylic derivatised mixtures for closed-loop insulin delivery","volume":"27","author":"Tanna","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2020.05.003_bib0020","doi-asserted-by":"crossref","first-page":"e016766","DOI":"10.1136\/bmjopen-2017-016766","volume":"8","author":"Pollard","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.drudis.2020.05.003_bib0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/(SICI)1099-0895(199812)14:4<303::AID-DMR243>3.0.CO;2-E","article-title":"Islet transplantation: present and future perspectives","volume":"14","author":"Kenyon","year":"1998","journal-title":"Diabetes Metab. Rev."},{"key":"10.1016\/j.drudis.2020.05.003_bib0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2337\/diab.16.1.35","article-title":"Method for the isolation of intact islets of Langerhans from the rat pancreas","volume":"16","author":"Lacy","year":"1967","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2020.05.003_bib0035","first-page":"83","article-title":"Diabetes. Islet cell transplantation","volume":"23","author":"Shapiro","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2020.05.003_bib0040","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1097\/TXD.0000000000000863","article-title":"Reconstruction of a pancreatic allograft with variant arterial anatomy for transplantation","volume":"5","author":"Adamson","year":"2019","journal-title":"Transplant. Direct."},{"key":"10.1016\/j.drudis.2020.05.003_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206449","article-title":"Improved islet recovery and efficacy through co-culture and co-transplantation of islets with human adipose-derived mesenchymal stem cells","volume":"13","author":"Gamble","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2020.05.003_bib0050","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1016\/j.transproceed.2005.09.044","article-title":"Insulin independence of unstable diabetic patient after single living donor islet transplantation","volume":"37","author":"Matsumoto","year":"2005","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.drudis.2020.05.003_bib0055","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2337\/db18-0788","article-title":"Posttransplant characterization of long-term functional hESC-derived pancreatic endoderm grafts","volume":"68","author":"Pepper","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2020.05.003_bib0060","first-page":"153","article-title":"Clinical islet transplantation at the University of Alberta\u2013the Edmonton experience","volume":"2005","author":"Truong","year":"2005","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.drudis.2020.05.003_bib0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sctm.17-0139","article-title":"Autologous mesenchymal stem cell and islet cotransplantation: safety and efficacy","volume":"7","author":"Wang","year":"2018","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.drudis.2020.05.003_bib0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1634\/stemcells.21-4-377","article-title":"Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes","volume":"21","author":"Zorina","year":"2003","journal-title":"Stem Cells"},{"key":"10.1016\/j.drudis.2020.05.003_bib0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fendo.2019.00101","article-title":"Endogenous pancreatic beta cell regeneration: a potential strategy for the recovery of beta cell deficiency in diabetes","volume":"10","author":"Zhong","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.drudis.2020.05.003_bib0080","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.2337\/db12-1281","article-title":"Recovery from overt type 1 diabetes ensues when immune tolerance and beta-cell formation are coupled with regeneration of endothelial cells in the pancreatic islets","volume":"62","author":"Wan","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2020.05.003_bib0085","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1176\/appi.psy.45.4.354","article-title":"Immunosuppressants","volume":"45","author":"Fireman","year":"2004","journal-title":"Psychosomatics"},{"key":"10.1016\/j.drudis.2020.05.003_bib0090","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.bbmt.2014.03.029","article-title":"Depletion of host CCR7(+) dendritic cells prevented donor T cell tissue tropism in anti-CD3-conditioned recipients","volume":"20","author":"He","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.drudis.2020.05.003_bib0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.18773\/austprescr.2016.053","article-title":"Rituximab in autoimmune diseases","volume":"39","author":"Randall","year":"2016","journal-title":"Aust. Prescr."},{"key":"10.1016\/j.drudis.2020.05.003_bib0100","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1073\/pnas.0712051105","article-title":"HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen","volume":"105","author":"Li","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2020.05.003_bib0105","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/blood-2008-06-165522","article-title":"Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI","volume":"113","author":"Li","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2020.05.003_bib0110","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4049\/jimmunol.178.2.838","article-title":"Donor CD8+ T cells mediate graft-versus-leukemia activity without clinical signs of graft-versus-host disease in recipients conditioned with anti-CD3 monoclonal antibody","volume":"178","author":"Zhang","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2020.05.003_bib0115","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1517\/17425250802525496","article-title":"Clinical immunotoxicity of therapeutic proteins","volume":"4","author":"Descotes","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.drudis.2020.05.003_bib0120","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4161\/mabs.1.2.7909","article-title":"Immunotoxicity of monoclonal antibodies","volume":"1","author":"Descotes","year":"2009","journal-title":"MAbs"},{"key":"10.1016\/j.drudis.2020.05.003_bib0125","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1517\/14712591003598843","article-title":"Teplizumab therapy for type 1 diabetes","volume":"10","author":"Masharani","year":"2010","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.drudis.2020.05.003_bib0130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41574-019-0233-3","article-title":"Teplizumab delays onset of type 1 diabetes mellitus","volume":"15","author":"Morris","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.drudis.2020.05.003_bib0135","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.drudis.2019.11.016","article-title":"Cell-based immunomodulatory therapy approaches for type 1 diabetes mellitus","volume":"25","author":"Black","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2020.05.003_bib0140","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27459","article-title":"Comparison of conditioning regimens for autologous stem cell transplantation in children with acute myeloid leukemia: a nationwide retrospective study in Japan","volume":"66","author":"Sakaguchi","year":"2019","journal-title":"Pediatr. Blood Cancer."},{"key":"10.1016\/j.drudis.2020.05.003_bib0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jimd.12044","article-title":"Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning for adult cerebral X-linked adrenoleukodystrophy","volume":"42","author":"Waldhuter","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.drudis.2020.05.003_bib0150","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1182\/blood.V81.10.2473.2473","article-title":"Competitive repopulation in unirradiated normal recipients","volume":"81","author":"Harrison","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2020.05.003_bib0155","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1073\/pnas.1801480116","article-title":"Clonal-level lineage commitment pathways of hematopoietic stem cells in vivo","volume":"116","author":"Lu","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2020.05.003_bib0160","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6053764","article-title":"HLA Class II allele, haplotype, and genotype associations with type 1 diabetes in Benin: a pilot study","volume":"2017","author":"Fagbemi","year":"2017","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.drudis.2020.05.003_bib0165","first-page":"780","article-title":"HLA genotyping in the international Type 1 Diabetes Genetics Consortium","volume":"74","author":"Mychaleckyj","year":"2010","journal-title":"Clin. Trials"},{"key":"10.1016\/j.drudis.2020.05.003_bib0170","first-page":"200","article-title":"Genetics of the HLA region in the prediction of type 1 diabetes","volume":"42","author":"Noble","year":"2011","journal-title":"Curr. Diab Rep."},{"key":"10.1016\/j.drudis.2020.05.003_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1375.001","article-title":"The Type 1 diabetes genetics consortium","volume":"1079","author":"Rich","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drudis.2020.05.003_bib0180","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2337\/db10-0827","article-title":"Induction of mixed chimerism with MHC-mismatched but not matched bone marrow transplants results in thymic deletion of host-type autoreactive T-cells in NOD mice","volume":"60","author":"Racine","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2020.05.003_bib0185","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.2337\/db13-1532","article-title":"Induction of mixed chimerism depletes pre-existing and de novo-developed autoreactive B cells in autoimmune NOD mice","volume":"63","author":"Racine","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2020.05.003_bib0190","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4049\/jimmunol.1401584","article-title":"MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice","volume":"194","author":"Racine","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2020.05.003_bib0195","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.4049\/jimmunol.1401137","article-title":"MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients","volume":"193","author":"Wang","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2020.05.003_bib0200","first-page":"E2329","article-title":"MHC-mismatched mixed chimerism restores peripheral tolerance of noncross-reactive autoreactive T cells in NOD mice","volume":"115","author":"Zhang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2020.05.003_bib0205","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13287-019-1347-1","article-title":"Transplantation of MHC-mismatched mouse embryonic stem cell-derived thymic epithelial progenitors and MHC-matched bone marrow prevents autoimmune diabetes","volume":"10","author":"Su","year":"2019","journal-title":"Stem Cell. Res. Ther."},{"key":"10.1016\/j.drudis.2020.05.003_bib0210","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.2337\/db13-0094","article-title":"HLA class II genotyping of African American type 1 diabetic patients reveals associations unique to African haplotypes","volume":"62","author":"Noble","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2020.05.003_bib0215","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007732","article-title":"Genetics of type 1 diabetes","volume":"2","author":"Noble","year":"2012","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"10.1016\/j.drudis.2020.05.003_bib0220","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.2337\/db10-0699","article-title":"HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 diabetes genetics consortium","volume":"59","author":"Noble","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2020.05.003_bib0225","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaut.2015.07.014","article-title":"Immunogenetics of type 1 diabetes: a comprehensive review","volume":"64","author":"Noble","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.drudis.2020.05.003_bib0230","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2337\/dc18-0288","article-title":"Identical and nonidentical twins: risk and factors involved in development of islet autoimmunity and type 1 diabetes","volume":"42","author":"Triolo","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.drudis.2020.05.003_bib0235","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1399-5448.2011.00774.x","article-title":"The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants","volume":"12","author":"Hagopian","year":"2011","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.drudis.2020.05.003_bib0240","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3389\/fendo.2019.00592","article-title":"Environmental factors associated with type 1 diabetes","volume":"10","author":"Esposito","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.drudis.2020.05.003_bib0245","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3390\/nu10091291","article-title":"Dietary cows\u2019 milk protein A1 beta-casein increases the incidence of T1DM in NOD mice","volume":"10","author":"Chia","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.drudis.2020.05.003_bib0250","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/nu9050482","article-title":"The impact of diet wheat source on the onset of type 1 diabetes mellitus-lessons learned from the non-obese diabetic (NOD) mouse model","volume":"9","author":"Gorelick","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.drudis.2020.05.003_bib0255","doi-asserted-by":"crossref","DOI":"10.3390\/nu11122937","article-title":"The role of vitamin D and omega-3 PUFAs in islet transplantation","volume":"11","author":"Infante","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.drudis.2020.05.003_bib0260","doi-asserted-by":"crossref","first-page":"e028578","DOI":"10.1136\/bmjopen-2018-028578","article-title":"Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol","volume":"9","author":"Ziegler","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.drudis.2020.05.003_bib0265","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/tcrm.1.1.15.53606","article-title":"Principles in genetic risk assessment","volume":"1","author":"Baptista","year":"2005","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.drudis.2020.05.003_bib0270","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/gepi.1370070302","article-title":"An epidemiologic approach to gene-environment interaction","volume":"7","author":"Ottman","year":"1990","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.drudis.2020.05.003_bib0275","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/aje\/kwh101","article-title":"Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker","volume":"159","author":"Pepe","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drudis.2020.05.003_bib0280","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/tpj.2016.6","article-title":"Role of the C1858T polymorphism of protein tyrosine phosphatase non-receptor type 22 (PTPN22) in children and adolescents with type 1 diabetes","volume":"17","author":"Blasetti","year":"2017","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.drudis.2020.05.003_bib0285","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2337\/db11-0386","article-title":"Effect of the PTPN22 and INS risk genotypes on the progression to clinical type 1 diabetes after the initiation of beta-cell autoimmunity","volume":"61","author":"Lempainen","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2020.05.003_bib0290","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.2337\/diabetes.53.7.1884","article-title":"Remapping the insulin gene\/IDDM2 locus in type 1 diabetes","volume":"53","author":"Barratt","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2020.05.003_bib0295","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00251-006-0088-3","article-title":"Association analysis of the AIRE and insulin genes in Finnish type 1 diabetic patients","volume":"58","author":"Turunen","year":"2006","journal-title":"Immunogenetics"},{"key":"10.1016\/j.drudis.2020.05.003_bib0300","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm.4289","article-title":"Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes","volume":"23","author":"Kracht","year":"2017","journal-title":"Nat. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.drudis.2020.05.003_bib0305","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1038\/gene.2009.88","article-title":"Remapping the type I diabetes association of the CTLA4 locus","volume":"10","author":"Qu","year":"2009","journal-title":"Genes Immun."},{"key":"10.1016\/j.drudis.2020.05.003_bib0310","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.gene.2012.12.030","article-title":"Association between cytotoxic T lymphocyte antigen-4 polymorphism and type 1 diabetes: a meta-analysis","volume":"516","author":"Chen","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.drudis.2020.05.003_bib0315","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.gde.2018.03.009","article-title":"Clinical and research uses of genetic risk scores in type 1 diabetes","volume":"50","author":"Sharp","year":"2018","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.drudis.2020.05.003_bib0320","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1542\/peds.2013-1652","article-title":"Genetic and epigenetic factors in etiology of diabetes mellitus type 1","volume":"132","author":"Stankov","year":"2013","journal-title":"Pediatrics"},{"issue":"Suppl. 22","key":"10.1016\/j.drudis.2020.05.003_bib0325","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/pedi.12327","article-title":"Genetic susceptibility to type 1 diabetes in childhood - estimation of HLA class II associated disease risk and class II effect in various phases of islet autoimmunity","volume":"17","author":"Ilonen","year":"2016","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.drudis.2020.05.003_bib0330","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/cam4.247","article-title":"Outcomes after (90) Yttrium-ibritumomab tiuxetan-BEAM in diffuse large B-cell lymphoma: a meta-analysis","volume":"3","author":"Auger-Quittet","year":"2014","journal-title":"Cancer. Med."},{"key":"10.1016\/j.drudis.2020.05.003_bib0335","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00432-016-2134-3","article-title":"Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed\/refractory Hodgkin lymphoma: a single-center analysis","volume":"142","author":"Rabitsch","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.drudis.2020.05.003_bib0340","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1097\/TP.0000000000001837","article-title":"HSCT-based approaches for tolerance induction in renal transplant","volume":"101","author":"Chhabra","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.drudis.2020.05.003_bib0345","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3324\/haematol.2009.017038","article-title":"Stem cell transplantation for autoimmune diseases","volume":"95","author":"Hugle","year":"2010","journal-title":"Haematologica"},{"issue":"Suppl. 2","key":"10.1016\/j.drudis.2020.05.003_bib0350","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41409-019-0620-3","article-title":"Transplantation tolerance in nonhuman primates and humans","volume":"54","author":"Sykes","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.drudis.2020.05.003_bib0355","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/sctm.16-0358","article-title":"Mechanisms of tolerance induction by hematopoietic chimerism: the immune perspective","volume":"6","author":"Yolcu","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.drudis.2020.05.003_bib0360","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jaut.2007.12.011","article-title":"A novel method of bone marrow transplantation (BMT) for intractable autoimmune diseases","volume":"30","author":"Ikehara","year":"2008","journal-title":"J. Autoimmun."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644620301951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644620301951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:48:10Z","timestamp":1761223690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644620301951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":72,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1359644620301951"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2020.05.003","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic profile considerations for induction of allogeneic chimerism as a therapeutic approach for type 1 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2020.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}